These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 19447134

  • 1. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides.
    Rusnati M, Vicenzi E, Donalisio M, Oreste P, Landolfo S, Lembo D.
    Pharmacol Ther; 2009 Sep; 123(3):310-22. PubMed ID: 19447134
    [Abstract] [Full Text] [Related]

  • 2. Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus.
    Lembo D, Donalisio M, Rusnati M, Bugatti A, Cornaglia M, Cappello P, Giovarelli M, Oreste P, Landolfo S.
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1374-81. PubMed ID: 18250186
    [Abstract] [Full Text] [Related]

  • 3. Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmission.
    Pacciarini F, Ghezzi S, Pinna D, Cima S, Zoppetti G, Oreste P, Poli G, Vicenzi E.
    New Microbiol; 2004 Apr; 27(2 Suppl 1):5-9. PubMed ID: 15646059
    [Abstract] [Full Text] [Related]

  • 4. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
    Presta M, Oreste P, Zoppetti G, Belleri M, Tanghetti E, Leali D, Urbinati C, Bugatti A, Ronca R, Nicoli S, Moroni E, Stabile H, Camozzi M, Hernandez GA, Mitola S, Dell'Era P, Rusnati M, Ribatti D.
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
    [Abstract] [Full Text] [Related]

  • 5. Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
    Urbinati C, Bugatti A, Oreste P, Zoppetti G, Waltenberger J, Mitola S, Ribatti D, Presta M, Rusnati M.
    FEBS Lett; 2004 Jun 18; 568(1-3):171-7. PubMed ID: 15196942
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide.
    Pinna D, Oreste P, Coradin T, Kajaste-Rudnitski A, Ghezzi S, Zoppetti G, Rotola A, Argnani R, Poli G, Manservigi R, Vicenzi E.
    Antimicrob Agents Chemother; 2008 Sep 18; 52(9):3078-84. PubMed ID: 18573926
    [Abstract] [Full Text] [Related]

  • 7. Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.
    Cagno V, Donalisio M, Civra A, Volante M, Veccelli E, Oreste P, Rusnati M, Lembo D.
    Antimicrob Agents Chemother; 2014 Aug 18; 58(8):4782-94. PubMed ID: 24914125
    [Abstract] [Full Text] [Related]

  • 8. Sulfated derivatives of Escherichia coli K5 capsular polysaccharide are potent inhibitors of human cytomegalovirus.
    Mercorelli B, Oreste P, Sinigalia E, Muratore G, Lembo D, Palù G, Loregian A.
    Antimicrob Agents Chemother; 2010 Nov 18; 54(11):4561-7. PubMed ID: 20713657
    [Abstract] [Full Text] [Related]

  • 9. The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice.
    Donalisio M, Quaranta P, Chiuppesi F, Pistello M, Cagno V, Cavalli R, Volante M, Bugatti A, Rusnati M, Ranucci E, Ferruti P, Lembo D.
    Biomaterials; 2016 Apr 18; 85():40-53. PubMed ID: 26854390
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity.
    Neyts J, De Clercq E.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):8-12. PubMed ID: 7648289
    [Abstract] [Full Text] [Related]

  • 14. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M, De Clercq E.
    Gen Pharmacol; 1997 Oct 01; 29(4):497-511. PubMed ID: 9352294
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1.
    Pirrone V, Wigdahl B, Krebs FC.
    Antiviral Res; 2011 Jun 01; 90(3):168-82. PubMed ID: 21439325
    [Abstract] [Full Text] [Related]

  • 18. Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.
    Li P, Sheng J, Liu Y, Li J, Liu J, Wang F.
    Med Res Rev; 2013 May 01; 33(3):665-92. PubMed ID: 22495734
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.